[HTML][HTML] Estimating the burden of antimicrobial resistance: a systematic literature review
Background Accurate estimates of the burden of antimicrobial resistance (AMR) are needed
to establish the magnitude of this global threat in terms of both health and cost, and to …
to establish the magnitude of this global threat in terms of both health and cost, and to …
Role of oxidative stress in the pathology and management of human tuberculosis
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, is the leading
cause of mortality worldwide due to a single infectious agent. The pathogen spreads …
cause of mortality worldwide due to a single infectious agent. The pathogen spreads …
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America …
Prevention, European Respiratory Society, and Infectious Diseases Society of America …
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study
SE Borisov, K Dheda, M Enwerem… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-
resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
[HTML][HTML] Costs to health services and the patient of treating tuberculosis: a systematic literature review
YV Laurence, UK Griffiths, A Vassall - Pharmacoeconomics, 2015 - Springer
Background Novel tuberculosis (TB) drugs and the need to treat drug-resistant tuberculosis
(DR-TB) are likely to bring about substantial transformations in TB treatment in coming …
(DR-TB) are likely to bring about substantial transformations in TB treatment in coming …
Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
The treatment of multidrug-resistant (MDR) or extensively drug-resistant (XDR) tuberculosis
(TB) remains a challenge for clinicians for several reasons, including the large number of …
(TB) remains a challenge for clinicians for several reasons, including the large number of …
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically …
K Dheda, JD Limberis, E Pietersen… - The lancet Respiratory …, 2017 - thelancet.com
Background The emergence of programmatically incurable tuberculosis threatens to
destabilise control efforts. The aim of this study was to collect prospective patient-level data …
destabilise control efforts. The aim of this study was to collect prospective patient-level data …
[HTML][HTML] Tuberculosis elimination: where are we now?
Tuberculosis (TB) still represents a major public health issue in spite of the significant impact
of the efforts made by the World Health Organization (WHO) and partners to improve its …
of the efforts made by the World Health Organization (WHO) and partners to improve its …
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
R Moodley, TR Godec - European Respiratory Review, 2016 - Eur Respiratory Soc
Multidrug-resistant (MDR) tuberculosis (TB) is a threat to global TB control, as suboptimal
and poorly tolerated treatment options have resulted in largely unfavourable outcomes for …
and poorly tolerated treatment options have resulted in largely unfavourable outcomes for …
Multidrug-resistant tuberculosis around the world: what progress has been made?
D Falzon, F Mirzayev, F Wares… - European …, 2015 - Eur Respiratory Soc
Multidrug-resistant tuberculosis (MDR-TB)(resistance to at least isoniazid and rifampicin) will
influence the future of global TB control. 88% of estimated MDR-TB cases occur in middle-or …
influence the future of global TB control. 88% of estimated MDR-TB cases occur in middle-or …